Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Fraser

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Herpes simplex type 1 DNA in human brain tissueN W Fraser, W C Lawrence, Z Wroblewska, et al.
Virology|November 1, 1996
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal gangliaJ Maggioncalda, A Mehta, Y H Su, et al.
Journal of Virology|September 1, 1988
Latent herpes simplex virus type 1 transcription in human trigeminal gangliaI Steiner, J G Spivack, D R O'Boyle, et al.
Nature|June 2, 2006
Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcriptA Gupta, J J Gartner, P Sethupathy, et al.
Journal of Virology|November 1, 1990
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal gangliaW J Mitchell, S L Deshmane, A Dolan, et al.
The Journal of General Virology|September 1, 1994
Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cellsT Block, S Barney, J Masonis, et al.
The Journal of Investigative Dermatology|June 1, 1997
Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutantB P Randazzo, M G Bhat, S Kesari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1C G Miller, C Krummenacher, R J Eisenberg, et al.
Journal of Virology|December 1, 1993
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT regionM Nicosia, S L Deshmane, J M Zabolotny, et al.
Gene Therapy|May 22, 2009
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promotersT Husain, M A Passini, M K Parente, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Herpes simplex type 1 DNA in human brain tissueN W Fraser, W C Lawrence, Z Wroblewska, et al.
Virology|November 1, 1996
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal gangliaJ Maggioncalda, A Mehta, Y H Su, et al.
Journal of Virology|September 1, 1988
Latent herpes simplex virus type 1 transcription in human trigeminal gangliaI Steiner, J G Spivack, D R O'Boyle, et al.
Nature|June 2, 2006
Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcriptA Gupta, J J Gartner, P Sethupathy, et al.
Journal of Virology|November 1, 1990
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal gangliaW J Mitchell, S L Deshmane, A Dolan, et al.
The Journal of General Virology|September 1, 1994
Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cellsT Block, S Barney, J Masonis, et al.
The Journal of Investigative Dermatology|June 1, 1997
Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutantB P Randazzo, M G Bhat, S Kesari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1C G Miller, C Krummenacher, R J Eisenberg, et al.
Journal of Virology|December 1, 1993
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT regionM Nicosia, S L Deshmane, J M Zabolotny, et al.
Gene Therapy|May 22, 2009
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promotersT Husain, M A Passini, M K Parente, et al.
Pageof 12